Profile
| Role | Director |
|---|---|
| Notability | 30/100 |
Board memberships
- Pelthos Therapeutics Inc.
Updated Jul 16, 2026
Greenleaf Peter has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $37K.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-07 | PTHS | Pelthos Therapeutics Inc. | S — Open-market sale | 85 | $27.27 | $2K |
| 2026-07-07 | PTHS | Pelthos Therapeutics Inc. | S — Open-market sale | 712 | $26.00 | $19K |
| 2026-04-06 | PTHS | Pelthos Therapeutics Inc. | S — Open-market sale [10b5-1] | 377 | $21.36 | $8K |
| 2026-04-06 | PTHS | Pelthos Therapeutics Inc. | S — Open-market sale [10b5-1] | 420 | $20.52 | $9K |
| 2026-04-01 | PTHS | Pelthos Therapeutics Inc. | A — Grant or award | 25.5K | $0.00 | |
| 2026-03-03 | AUPH | Aurinia Pharmaceuticals Inc. | F — Tax withholding / forfeiture | 100.9K | $14.21 | $1.43M |
| 2026-03-03 | AUPH | Aurinia Pharmaceuticals Inc. | A — Grant or award | 196.4K | $0.00 | |
| 2026-02-23 | AUPH | Aurinia Pharmaceuticals Inc. | F — Tax withholding / forfeiture | 100.2K | $14.40 | $1.44M |
Greenleaf Peter is a corporate insider — currently tracked as Director of Pelthos Therapeutics Inc. (PTHS). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($37K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Greenleaf Peter profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.